- Audio
NovoRapid® Penfill®
Consumer Medicine Information (CMI) summary
The full CMI on the next page has more details. If you are worried about using this medicine,
speak to your doctor, diabetes education nurse, or pharmacist.
NovoRapid® contains the active ingredient insulin aspart. Insulin aspart is a rapid-acting insulin
used to treat diabetes mellitus in adults and children.
For more information, see Section 1. Why am I using NovoRapid®? in the full CMI.
For more information, see Section 1. Why am I using NovoRapid®? in the full CMI.
Do not use if you have ever had an allergic reaction to insulin aspart or any of the
ingredients listed at the end of the CMI.
Talk to your doctor or pharmacist if you have any other medical conditions (especially
kidney, liver or gland problems), take any other medicines, or are pregnant or plan
to become pregnant or are breast-feeding.
For more information, see Section 2. What should I know before I use NovoRapid®?
in the full CMI.
Some medicines may interfere with NovoRapid® and affect how it works.
A list of these medicines is in Section 3. What if I am taking other medicines? in the full CMI.
A list of these medicines is in Section 3. What if I am taking other medicines? in the full CMI.
Use immediately (up to 10 minutes) before your meal or carbohydrate snack. Inject
into the abdomen, thighs, buttocks or upper arms.
Change your injection site regularly. Carefully follow the advice on how to inject
under the skin.
Detailed instructions can be found in Section 4. How do I use NovoRapid®? in the full CMI.
|
Things you should do
|
Remind any doctor, dentist, pharmacist or diabetes education nurse you visit that
you have diabetes and are using insulin.
Measure your blood sugar levels regularly.
Tell your doctor if you often have hypos (low blood sugar levels).
Always carry some sugary food or fruit juice with you.
|
|---|---|
|
Things you should not do
|
Do not stop using your medicine unless your doctor tells you to.
Do not use the medicine if you think it has been frozen or exposed to excessive heat.
|
|
Driving or using machines
|
If your blood sugar is low or high your concentration and ability to react might be
affected, and therefore also your ability to drive or operate a machine.
|
|
Drinking alcohol
|
Alcohol may mask the symptoms of hypos. If you drink alcohol, your need for insulin
may change.
|
|
Looking after your medicine
|
Store NovoRapid® Penfill® that are not being used between 2°C and 8°C in a refrigerator (not in or too near the freezer section or
cooling element).
You can keep the NovoRapid® Penfill®
that you are using, or that you are carrying as a spare, either at room temperature (not above 30°C) or in a refrigerator (2°C to 8°C) for up to
4 weeks. Discard NovoRapid® Penfill® after 4 weeks even if there is still some NovoRapid® left in it.
|
For more information, see Section 5. What should I know while using NovoRapid®? in the full CMI.
The most common side effect when using insulin is low blood sugar levels (a hypo).
Tell your relatives, friends, close workmates, teachers or carers that you have diabetes.
It is important that they can recognise the signs and symptoms of a hypo. For more information, including what to do if you have any side effects, see Section
6. Are there any side effects? in the full CMI.
NovoRapid® Penfill®
Active ingredient:
Insulin aspart
Consumer Medicine Information (CMI)
This leaflet provides important information about using NovoRapid®. You should also speak to your doctor or pharmacist if you would like further information
or if you have any concerns or questions about using NovoRapid
®
.
Where to find information in this leaflet:
The insulin aspart, or "NovoRapid
®
", in NovoRapid
®
Penfill
®
is a rapid-acting insulin.
NovoRapid
®
is used to treat diabetes mellitus in adults and children. Diabetes mellitus is a condition where your pancreas does not produce enough insulin
to control your blood sugar (glucose) level. Extra insulin is therefore needed.
There are two types of diabetes mellitus:
Type 1 diabetes
Type 2 diabetes
Patients with type 1 diabetes always require insulin to control their blood sugar
levels.
Some patients with type 2 diabetes may also require insulin after initial treatment
with diet, exercise and tablets.
NovoRapid
® lowers your blood sugar level after injection. When injected under your skin, NovoRapid® has a faster onset of action than soluble human insulin. It takes effect within 10
to 20 minutes. Usually, the maximum effect will occur between 1-3 hours after injection
and the effect may last for up to 5 hours.
As with all insulins, the duration of action will vary according to the dose, injection
site, blood flow, temperature and level of physical activity. Due to its shorter duration
of action, NovoRapid® has a lower risk of causing nocturnal hypoglycaemic episodes.
Penfill
® is a pre-filled 3mL glass cartridge designed to be used with Novo Nordisk insulin
delivery systems (such as NovoPen®).
NovoRapid® is not addictive.
NovoRapid® Penfill® is available only with a doctor’s prescription.
Warnings
If you are blind or have poor eyesight and cannot read the dose counter on your insulin
delivery pen, do not use it without help. Get help from a person with good eyesight who is trained to use the pen.
Do not use NovoRapid
®
if:
you are allergic to a medicine containing insulin, or any of the ingredients listed
at the end of this leaflet.
Always check the ingredients to make sure you can use this medicine.
Some of the symptoms of an allergic reaction may include:
Always check the ingredients to make sure you can use this medicine.
Some of the symptoms of an allergic reaction may include:
redness, swelling, rash and itching at the injection site
rash, itching or hives on the skin
shortness of breath
wheezing or difficulty breathing
swelling of the face, lips, tongue or other parts of the body.
you are experiencing a low blood sugar level (a “hypo”) when the dose is due.
If you have a lot of hypos discuss appropriate treatment with your doctor.
If you have a lot of hypos discuss appropriate treatment with your doctor.
the expiry date printed on the pack has passed, or if the packaging is torn or shows
signs of tampering.
If it has expired or is damaged, return it to your pharmacist for disposal. The expiry date refers to the last day of that month.
If it has expired or is damaged, return it to your pharmacist for disposal. The expiry date refers to the last day of that month.
Check with your doctor or pharmacist if you:
have any other medical conditions such as kidney or liver problems, adrenal, pituitary
or thyroid gland problems
take any medicines for any other condition.
During treatment, you may be at risk of developing certain side effects. It is important
you understand these risks and how to monitor for them. See additional information
under Section 6. Are there any side effects?
Pregnancy and breast-feeding
Check with your doctor or pharmacist if you are pregnant or intend to become pregnant.
NovoRapid® can be used during pregnancy. Pregnancy may make managing your diabetes more difficult.
Insulin needs usually decrease during the first three months of pregnancy and increase
during the last six months. Your doctor can discuss with you the risks and benefits
involved.
Talk to your doctor or pharmacist if you are breast-feeding or intend to breast-feed.
There are no restrictions on treatment with NovoRapid® during breast-feeding.
Heart disease or stroke history
Inform your doctor as soon as possible if you experience signs of heart failure such
as unusual shortness of breath or rapid increase in weight or localised swelling (oedema).
Some patients with long-standing type 2 diabetes mellitus and heart disease or previous
stroke who are treated with thiazolidinediones in combination with insulin may develop
heart failure.
Tell your doctor or pharmacist if you are taking any other medicines, including any
medicines, vitamins or supplements that you buy without a prescription from your pharmacy,
supermarket or health food shop.
Some medicines may interfere with NovoRapid
®
and affect how it works.
This may mean that your insulin dose has to change.
Medicines that may
cause your blood sugar to fall
(hypoglycaemia):
other medicines used for the treatment of diabetes
monoamine oxidase inhibitors (MAOI) - used for the treatment of depression
alpha-blocking agents - used for the treatment of high blood pressure and to relieve
difficulty in passing urine caused by an enlarged prostate
non-selective beta-blocking agents - used for the treatment of certain heart conditions
and high blood pressure which may also mask the symptoms of hypoglycaemia and delay
recovery from hypoglycaemia
angiotensin converting enzyme (ACE) inhibitors - used for the treatment of certain
heart conditions, high blood pressure or elevated protein/albumin in the urine
salicylates e.g. aspirin - used to relieve pain and lower fever
anabolic steroids - used to promote growth
sulfonamides - used to treat bacterial infections
quinine - used for the prevention of malaria and the relief of muscle cramps
quinidine - used for the control of heart problems.
Medicines that may
cause your blood sugar to rise
(hyperglycaemia):
glucocorticoids (except when applied locally) - used to treat inflammatory conditions
oral contraceptives (“the pill”) - used for birth control
thiazides, frusemide or ethacrynic acid - used for the treatment of high blood pressure
or fluid retention (oedema)
thyroid hormones - used for the treatment of malfunction of the thyroid gland
sympathomimetics - used for the treatment of asthma
growth hormone - used to treat growth disorders
danazol - used to treat endometriosis, menorrhagia, fibrocystic breast disease and
hereditary angioedema
oxymetholone - used to treat certain blood disorders
diazoxide - used for the treatment of high blood pressure
nicotinic acid - used for the treatment of high cholesterol levels in the blood
asparaginase - used to treat leukaemia and lymph gland tumours.
Medicines that may
cause your blood sugar to rise or fall:
octreotide - used to treat gastrointestinal endocrine tumours and enlargement of parts
of the body (e.g. hands, feet, head) caused by abnormal growth hormone levels
lanreotide - used to treat enlargement of parts of the body (e.g. hands, feet, head)
caused by abnormal hormone levels.
Check with your doctor or pharmacist if you are not sure about what medicines, vitamins
or supplements you are taking and if these affect NovoRapid
®
.
Your doctor, diabetes education nurse or pharmacist will have given you advice on
how to use your medicine. Carefully follow all the directions. They may differ from the information contained in this leaflet.
Your doctor may also want you to use another insulin such as Protaphane® or Levemir®.
Any change in dose or type of insulin should be made cautiously and only under medical
supervision.
If you change the type of insulin that you use, you may have to use more or less than
before. This may happen with the first dose or over a period of time.
How much to use
Your doctor or diabetes education nurse will tell you how much of this medicine you
need to use.
It is very important that you manage your diabetes carefully. Too much or too little
insulin can cause serious effects.
When to use NovoRapid®
NovoRapid® should normally be used immediately (up to 10 minutes) before your meal or carbohydrate
snack. When necessary, NovoRapid® may be used immediately after the meal.
How to use NovoRapid®
NovoRapid® Penfill® is designed to be used with Novo Nordisk insulin delivery systems and NovoFine® needles.
Carefully follow the instructions on how to use your Novo Nordisk insulin delivery
system.
Do not use the insulin level indicator on the insulin delivery system to measure your
dose of NovoRapid®.
If you use more than one type of Penfill® (more than one type of insulin), you must use a separate insulin delivery system
for each type of Penfill®.
Take care not to drop or knock the insulin delivery system that contains NovoRapid® Penfill®.
As a precautionary measure, always carry a spare Penfill® in case your in-use Penfill® is lost or damaged.
Inject NovoRapid® under the skin (subcutaneous injection) as shown to you by your doctor or diabetes
education nurse.
In an emergency, the insulin contained within NovoRapid® Penfill® is suitable for intravenous administration, under medical supervision only. For emergency
use, the insulin must first be withdrawn from Penfill® into a syringe. Discard your Penfill
®
after emergency use.
Checking your NovoRapid
®
Penfill®:
Check your NovoRapid® Penfill® before each preparation and injection. Make sure you are using the correct type of
insulin.
Do not use this medicine if it is thickened, coloured, or has solid bits in it.
Always check the cartridge, including the rubber plunger (stopper). Do not use it
if any damage is seen or if there is a gap between the plunger and the white label
band.
If you note any of the above, return your Penfill® to your pharmacist - do not use your Penfill
®
.
Preparing a dose:
1. Wash your hands.
2. If your NovoRapid® Penfill® is already inside your insulin delivery system, check the amount of insulin remaining. If there is insufficient insulin for your dose, follow the relevant instructions in the system user manual.
3. Alternatively, or if your insulin delivery system does not already carry a Penfill® cartridge, load a new NovoRapid® Penfill®.
4. Disinfect the rubber membrane of Penfill® with an alcohol swab.
5. Attach a new NovoFine® needle.
Checking for insulin flow (priming)
Always check your Novo Nordisk insulin delivery system for insulin flow (priming)
before each injection, as described in the system user manual.
The priming procedure may highlight a malfunction with your insulin delivery system.
Priming also removes any air bubbles and helps indicate whether or not a needle is
broken.
Only dial up your required dose after you see a drop of insulin at the needle tip.
After priming, if you need to put the insulin delivery system down, make sure the
needle does not touch anything.
Injecting a dose:
Choose a site for injection.
Inject NovoRapid
®
under the skin (subcutaneous injection) as shown by your doctor or diabetes education
nurse.
NovoRapid® may be injected into the abdomen, thighs, buttocks or upper arms.
Remember to change your injection site regularly as shown to you by your doctor or
diabetes education nurse. This may reduce the risk of developing a depression or thickening
of the skin around the injection site (lipodystrophy) (see Section 6. Are there any
side effects?).
Insert the needle into the skin, and inject the full dose of insulin under the skin.
Keep the needle under the skin for at least 6 seconds. Keep the push button fully
depressed until the needle has been withdrawn from the skin. This will ensure correct
delivery and limit possible flow of blood into the needle or insulin reservoir.
Apply gentle pressure over the injection site for several seconds.
Do not rub the area.
After injecting:
Dispose of your used needle safely into a yellow plastic sharps container after each
injection.
If you do not remove it, temperature changes may cause insulin to leak out of the
needle, which can cause inaccurate dosing.
Health care professionals, relatives and other carers should follow general precautionary
measures for removal and disposal of needles, to eliminate the risk of needlestick
injury.
It is recommended that you eat a meal or a snack containing carbohydrate within 10
minutes of the injection.
Do not share needles, cartridges or insulin delivery systems.
Leave Penfill
®
in the insulin delivery system until it needs to be replaced.
How long to use it
Do not stop using NovoRapid® Penfill® unless your doctor tells you to.
If you use too much NovoRapid® (overdose) - Hypoglycaemia
Your blood sugar level may become too low (you may experience hypoglycaemia or a “hypo”)
if you:
accidentally use too much of this medicine
have too much or unexpected exercise
delay eating meals or snacks
eat too little food
are ill.
The first symptoms of mild to moderate hypos can come on suddenly. They may include:
cold sweat, cool pale skin
fatigue, drowsiness, unusual tiredness and weakness
nervousness, anxious feeling, tremor, rapid heart beat
confusion, difficulty concentrating
excessive hunger
vision changes
headache, nausea.
Always carry some sugary food or fruit juice with you.
If you experience any of these symptoms of a hypo, immediately eat some sugary food
or have a sugary drink, e.g. lollies, biscuits or fruit juice, and measure your blood
sugar level.
Tell your relatives, friends, close workmates, teachers or carers that you have diabetes.
It is important that they recognise the signs and symptoms of a hypo.
Make sure they know to give you some sugary food or fruit juice for mild to moderate
symptoms of a hypo.
If you lose consciousness, make sure they know:
to turn you on your side and get medical help immediately
not to give you anything to eat or drink.
This is because you could choke.
An injection of the hormone glucagon may speed up recovery from unconsciousness. This
can be given by a relative, friend, workmate or carer who knows how to give it.
If glucagon is used, eat some sugary food or have a sugary drink as soon as you are
conscious again.
If you do not feel better after this, contact your doctor, diabetes education nurse,
or the closest hospital.
If you do not respond to glucagon treatment, you will require medical attention.
See your doctor if you keep having hypo reactions, or if you have ever become unconscious
after using insulin.
Your insulin dose may need to be changed.
If a severe hypo is not treated, it can cause brain damage and even death.
If you think that you have used too much NovoRapid®, you may need urgent medical attention.
You should immediately:
contact your doctor, or
go to the Accident and Emergency department at your nearest hospital, or
phone the Poisons Information Centre (by calling
13 11 26).
13 11 26).
You should do this even if there are no signs of discomfort or poisoning.
If you miss a dose - Hyperglycaemia
If you forget your insulin dose, test your blood sugar level as soon as possible.
If you are not sure what to do, talk to your doctor, diabetes education nurse or pharmacist.
Do not use a double dose of your insulin.
If it is almost time for your next dose, skip the dose you missed and use your next
dose when you are meant to.
Otherwise, use it as soon as you remember - don’t forget to eat some carbohydrate
within 10 minutes of your injection – and then go back to using it as you would normally.
Your blood sugar levels may become high (hyperglycaemia) if you:
miss doses of insulin or use less insulin than you need
have uncontrolled diabetes
exercise less than usual
eat more carbohydrates than usual
are ill or stressed.
High blood sugar levels over a long period of time can lead to too much acid in the
blood (diabetic ketoacidosis).
Contact your doctor immediately if your blood sugar level is high or you recognise
any of the following symptoms.
Symptoms of mild to moderate hyperglycaemia include:
drowsy feeling
flushed face
thirst, loss of appetite
fruity odour on the breath
blurred vision
passing larger amounts of urine than usual
getting up at night more often than usual to pass urine
high levels of glucose and acetone in the urine.
Symptoms of severe hyperglycaemia include:
heavy breathing
fast pulse
nausea, vomiting
dehydration
loss of consciousness.
Severe hyperglycaemia can lead to unconsciousness and in extreme cases death if untreated.
Discuss any worries you may have about this with your doctor, diabetes education nurse
or pharmacist.
Things you should do
Measure your blood sugar level regularly.
Make sure all friends, relatives, workmates, teachers or carers know that you have
diabetes.
If your child has diabetes it is important to tell their carers.
Keep using your insulin even if you feel well.
It helps to control your condition, but does not cure it.
Tell your doctor if you often have hypos (low blood sugar levels).
Your doctor may need to adjust your insulin dose.
Always carry some sugary food or fruit juice with you.
If you experience any of the symptoms of a hypo, immediately eat some sugary food
or have a sugary drink, e.g. lollies, biscuits or fruit juice.
Tell your doctor if you have trouble recognising the symptoms of hypos.
Under certain conditions, the early warning signs of hypos can be different or less
obvious. Your doctor may need to adjust your insulin dose.
Remind any doctor, dentist or pharmacist or other health professionals you visit that
you have diabetes and are using insulin.
Tell your doctor, diabetes education nurse or pharmacist if you are travelling.
Ask them for a letter explaining why you are taking injecting devices with you. Each
country you visit will need to see this letter, so you should take several copies.
You may need to inject your insulin and eat your meals at different times because
of time differences in and between countries.
You may not be able to get the same type of insulin in the country you are visiting.
Your doctor, diabetes education nurse or pharmacist can provide you with some helpful
information.
Things you should not do
Do not stop using your medicine unless your doctor tells you to.
Do not use the medicine if you think it has been frozen or exposed to excessive heat.
It will not work as well.
Do not refill your NovoRapid
®
Penfill
®
.
Do not use this medicine to treat any other complaints unless your doctor tells you
to.
Do not give your medicine to anyone else, even if they have the same condition as
you.
Do not share needles, cartridges and insulin delivery systems.
Things to be careful of
Tell your doctor if you are ill.
Illness, especially with nausea and vomiting, may cause your insulin needs to change.
Even if you are not eating, you still require insulin. You and your doctor should
design an insulin plan for those times when you are sick.
Tell your doctor if you are exercising more than usual.
Exercise may lower your need for this medicine. Exercise may also speed up the effect
of a dose of it, especially if the exercise involves the area of the injection site
(e.g. the thigh should not be used for injection prior to jogging or running).
Tell your doctor if your diet changes.
Changes in diet may cause your insulin needs to change.
Tell your doctor if you notice any skin changes at the injection site.
If you inject insulin at the same place, the fatty tissue may shrink (lipoatrophy)
or thicken (lipohypertrophy). Lumps under the skin may also be caused by build-up
of a protein called amyloid (cutaneous amyloidosis). The insulin may not work very
well if you inject into a lumpy, shrunken or thickened area. Change the injection
site with each injection to help prevent these skin changes.
Tell your doctor if you are currently injecting into these affected areas before you
start injecting in a different area. Your doctor may tell you to check your blood sugar more closely, and to adjust your
insulin or your other antidiabetic medications dose.
Driving or using machines
Be careful before you drive or use any machines or tools until you know how the insulin
affects you.
If your blood sugar is low or high your concentration and ability to react might be
affected, and therefore also your ability to drive or operate a machine. Bear in mind
that you could endanger yourself or others. Please ask your doctor whether you can
drive a car:
if you have frequent hypos
if you find it hard to recognise hypoglycaemia.
Drinking alcohol
Tell your doctor or pharmacist if you drink alcohol.
Alcohol may mask the symptoms of hypos. If you drink alcohol, your need for insulin
may change as your blood sugar level may either rise or fall. Careful monitoring is
recommended.
Looking after your medicine
Store NovoRapid® Penfill®
that are not being used between 2°C and 8°C in a refrigerator (not in or too near the freezer section or
cooling element).
Do not keep the NovoRapid® Penfill®
that you are using, or that you are carrying as a spare, in a refrigerator.
You can use it up to 4 weeks below 30°C after taking it out of the refrigerator.
Discard NovoRapid
®
Penfill
®
after 4 weeks even if there is still some NovoRapid
®
left in it.
The NovoRapid® in your NovoRapid® Penfill® must not be frozen, or exposed to excessive heat or light. Protect the NovoRapid® in NovoRapid® Penfill® from light by keeping the cartridges in the carton when not in use.
Never use NovoRapid® Penfill® after the expiry date printed on the label and carton. The expiry date refers to
the last day of that month.
Never use NovoRapid® Penfill® if the solution is not clear and colourless.
Keep out of the reach of children.
Disposal of your medicine
Discard in-use NovoRapid® Penfill® after 4 weeks even if there is still some NovoRapid® left in it.
Dispose of used needles and syringes safely into a yellow plastic sharps container.
Getting rid of any unwanted medicine
If you no longer need to use this medicine or it is out of date, take it to any pharmacy
for safe disposal.
Do not use this medicine after the expiry date. The expiry date refers to the last
day of that month.
All medicines can have side effects. If you do experience any side effects, most of
them are minor and temporary. However, some side effects may need medical attention.
Ask your doctor or pharmacist to answer any questions you have. Tell your doctor,
diabetes education nurse or pharmacist as soon as possible if you do not feel well
while you are using NovoRapid
®
Penfill
®
.
Common side effects
|
Less serious side effects
|
What to do
|
|---|---|
|
The most common side effect when using insulin is low blood sugar levels (a hypo).
Mild to moderate
Other effects:
pain, redness, hives, bruising, swelling or itching at the injection site.
Usually these symptoms disappear within a few weeks during continued use. If you have serious or continuing reactions, you may need to stop using NovoRapid® and use another insulin. a depression or thickening of the skin around the injection site (lipodystrophy).
lumps under your skin (cutaneous amyloidosis).
when you first start your insulin treatment you may get visual problems or swollen
hands and feet.
|
Speak to your doctor, diabetes education nurse or pharmacist if you have any of these
less serious side effects and they worry you.
They are usually mild and short-lived.
|
Serious side effects
|
Serious side effects
|
What to do
|
|---|---|
|
Symptoms of severe low blood sugar levels:
disorientation
seizures, fits or convulsions
loss of consciousness.
If a severe hypo is not treated, it can cause brain damage and death.
Other effects:
skin rashes over a large part of the body
shortness of breath, wheezing
swelling of the face, lips or tongue
fast pulse
sweating.
|
Tell your doctor immediately or go to Accident and Emergency at your nearest hospital
if you notice any of these serious side effects.
You may need urgent medical attention or hospitalisation. These side effects are very
rare.
|
Tell your doctor if you notice anything else that may be making you feel unwell.
Other side effects not listed here may occur in some people.
Reporting side effects
After you have received medical advice for any side effects you experience, you can
report side effects to the Therapeutic Goods Administration online at www.tga.gov.au/reporting-problems . By reporting side effects, you can help provide more information on the safety of
this medicine.
What NovoRapid® contains
|
Active ingredient
(main ingredient)
|
insulin aspart 100 units per mL (100 U/mL)
|
|---|---|
|
Other ingredients
(inactive ingredients)
|
glycerol, phenol, metacresol, zinc chloride, sodium chloride, dibasic sodium phosphate
dihydrate, sodium hydroxide, hydrochloric acid and water for injections.
|
Do not take this medicine if you are allergic to any of these ingredients.
What NovoRapid® looks like
NovoRapid® is a clear, colourless solution for subcutaneous injection.
NovoRapid® Penfill® is a pre-filled 3mL glass cartridge designed to be used with Novo Nordisk insulin
delivery systems. (AUST R 133444)
Who distributes NovoRapid®
NovoRapid® Penfill® is supplied in Australia by:
Novo Nordisk Pharmaceuticals Pty Ltd
Level 10
118 Mount Street
North Sydney NSW 2060
Australia
NovoRapid® Penfill® is supplied in New Zealand by:
Novo Nordisk Pharmaceuticals Ltd.
11-19 Customs Street West
Commercial Bay Tower, Level 18, Office 1834
Auckland 1010
New Zealand
NovoRapid®, Penfill®, Protaphane® Levemir® and NovoCare® are registered trademarks of Novo Nordisk A/S
© 2021
Novo Nordisk A/S
For further information:
For further information call the NovoCare® Customer Care Centre on 1800 668 626 (Australia) or 0800 733 737 (New Zealand).
You can also get more information about diabetes and insulin from:
Diabetes Australia:
freecall helpline 1300 136 588
Diabetes New Zealand:
This leaflet was prepared on 04 November 2021.
